Sopharma AD accounts net consolidated profit in size of 20.013 mln leva for the first six months of 2007, in comparison with 15 mln leva positive financial result for the past year.

On datas from the published of BFB-Sofia account of the pharmaceuctist assosiation the net incomes of the sellings are on value of 166.748 mln leva, and the grow from 65.271 mln leva for the past period.

The volume of the realized exportation for the first six months of 2007 is for around 27 mln $, which is with 39 % more than the achieved in the first six months of 2006. Its relativly part in the incomes is 55%.

Sopharma bring its production in 28 countries, and totaly 89% from it is for countries like Russia, Ukraine, Poland, Latvia, Belarus, etc.

The total expenses of the company for the first six months of 2007 come to 146.064 mln leva, while the financial expenses are 4.011 mln leva.

For the period 2007-2009 Sopharma AD plans to invest 163.85 , and the deposits in the new building, new activity and marketing.The general capital of the assosiation is 132 mln leva, and the private is 206.058 mln leva.

Sofia AD and Telso AD have accordingly 25.36 and 23.77% of the company, while Telekomplekt AD and Gramercy Emerging Markets Fund own respectively 20.42 and 17.26%

Yesterday on possitions were made 51 deals for 134.088 numbers to the total value of 1.019 mln leva. Minutes before the opening today the offerts buying/selling are on levels of 7.57/7.61 leva for one.